RhumbLine Advisers
PROK icon

RhumbLine Advisers’s ProKidney PROK Stock Holding History

RhumbLine Advisers’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-83,369
Closed -$73K – 4232
2025
Q1 		$73K Buy
83,369
+2,868
+4% +$3.98K ﹤0.01% 3482
2024
Q4 		$136K Sell
80,501
-9,892
-11% -$17.8K ﹤0.01% 3376
2024
Q3 		$174K Buy
90,393
+14,203
+19% +$32.2K ﹤0.01% 3306
2024
Q2 		$187K Buy
76,190
+6,181
+9% +$16.6K ﹤0.01% 3262
2024
Q1 		$115K Buy
70,009
+801
+1% +$1.18K ﹤0.01% 3398
2023
Q4 		$123K Buy
69,208
+564
+0.8% +$1.21K ﹤0.01% 3380
2023
Q3 		$314K Sell
68,644
-8,779
-11% -$84K ﹤0.01% 2910
2023
Q2 		$866K Buy
+77,423
New +$824K ﹤0.01% 2373

Other funds holding PROK

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BU
Brown University Providence, Rhode Island $102M AUM 26.79% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

RhumbLine Advisers's PROK Position: Q2 2025 in Review

RhumbLine Advisers sold out of ProKidney (PROK) in Q2 2025, closing a stake of 83,369 shares — an estimated $73K sold.

RhumbLine Advisers first reported a position in PROK in Q2 2023 and held it in 8 quarters. The position peaked at $866K in Q2 2023. 56 funds tracked by Wall St. Rank hold PROK as of Q2 2025.

  • RhumbLine Advisers reported no remaining ProKidney position as of Q2 2025 after selling out during the quarter.
  • RhumbLine Advisers sold 83,369 ProKidney shares in Q2 2025, an estimated $73K.
  • RhumbLine Advisers first reported a position in ProKidney in Q2 2023 and held it in 8 quarters.
  • RhumbLine Advisers's ProKidney position peaked at $866K in Q2 2023.
  • 56 funds tracked by Wall St. Rank held ProKidney as of Q2 2025.

Based on RhumbLine Advisers's 13F filing for Q2 2025, filed 12 Aug 2025.